OverviewSuggest Edit

Akelos is a research-based biopharmaceutical clinical company. It develops non-narcotic drugs for the treatment of neuropathic pain. The company aims to offer alternatives to opioid therapies.

Latest Updates

Employees (est.) (Oct 2020)2
Cybersecurity ratingBMore

Key People/Management at Akelos

Steven R. Fox

Steven R. Fox

Peter Hutt

Peter Hutt

FDA Counsel
Peter Goldstein

Peter Goldstein

Scientific Founder
Gareth R. Tibbs Ph

Gareth R. Tibbs Ph

Scientific Founder
Show more

Akelos Financials and Metrics

Summary Metrics

Founding Date


Akelos total Funding

$2.1 m

Akelos latest funding size

$1.80 m

Time since last funding

9 months ago

Akelos investors

Akelos's latest funding round in January 2020 was reported to be $1.8 m. In total, Akelos has raised $2.1 m
Show all financial metrics

Akelos Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Akelos Online and Social Media Presence

Embed Graph

Akelos Frequently Asked Questions

  • When was Akelos founded?

    Akelos was founded in 2018.

  • Who are Akelos key executives?

    Akelos's key executives are Steven R. Fox, Peter Hutt and Peter Goldstein.

  • How many employees does Akelos have?

    Akelos has 2 employees.

  • Who are Akelos competitors?

    Competitors of Akelos include RaQualia Pharma, SYNthesis Med Chem and Benchmark Research.